Harini Lakshman

Dr. Harini Lakshman

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2024 in Journal of Innovations in Cardiac Rhythm Management
Verified
Journal Article
Open access
HLHarini Lakshman
Harini Lakshman
MCMedhat Chowdhury
Medhat Chowdhury
AAAmmar Ahmed
Ammar Ahmed
EWEverett Woods
Everett Woods
GFGeorge Flemengos
George Flemengos
CBChristopher Bradley
Christopher Bradley
Clinical and Electrophysiological Outcomes of Left Bundle Area Pacing Compared to Biventricular Pacing: An Updated Meta-analysis

31 August 2023 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
HLHarini Lakshman
Harini Lakshman
SBSukriti Banthiya
Sukriti Banthiya
AAAmmar Ahmed
Ammar Ahmed
DSDipak Shah
Dipak Shah

1 September 2024
Verified
Preprint
Open access
AAAmmar Ahmed
Ammar Ahmed
CBChristopher Bradley
Christopher Bradley
MCMedhat Chowdhury
Medhat Chowdhury
PAPhanindra Antharam
Phanindra Antharam
HLHarini Lakshman
Harini Lakshman
Not-yet-known not-yet-known not-yet-known unknown Introduction: Transcatheter aortic valve implantation (TAVI) is a treatment for severe aortic stenosis in high-risk and intermediate-risk patients unsuitable for surgery. Despite its minimally invasive nature, TAVI often leads to complications, including de novo left bundle branch block (LBBB), which increases the risk of complete atrioventricular (AV) block, heart failure, and sudden cardiac death. Current guidelines provide ambiguous recommendations for permanent pacemaker (PPM) implantation for patients with LBBB post-TAVI. This report aims to reevaluate the HV interval cutoff and explore alternative predictors for PPM decisions in patients with LBBB after TAVI. Case Description: A 79-year-old female with non-obstructive coronary artery disease and severe symptomatic aortic stenosis underwent TAVI with a 26 mm Edwards Resilia balloon-expandable valve. Pre-TAVI electrocardiography (ECG) showed sinus rhythm with a QRS duration of 98 ms. Post-TAVI, the patient developed a first-degree AV delay and new-onset LBBB. An electrophysiological study (EPS) performed 48 hours post-TAVI showed an HV interval of 61 ms. Despite this, the patient developed symptomatic complete heart block hours later, necessitating urgent PPM implantation. Discussion: This case questions the reliability of the HV interval as a standalone marker for pacemaker decisions in LBBB post-TAVI patients. The occurrence of complete heart block despite an HV interval below predictive values raises concerns about this parameter’s accuracy. Alternative predictors such as the delta HV interval and AH interval may provide better insights. Delayed EPS assessment might be more appropriate. Conclusion: Managing LBBB after TAVI is complex. Reevaluation of HV interval reliability and larger trials to establish accurate predictors and refine PPM implantation criteria post-TAVI are needed to improve patient outcomes.

4 August 2023
Verified
Preprint
Open access
PDF file
HLHarini Lakshman
Harini Lakshman
AAAmmar Ahmed
Ammar Ahmed
SCSteven Coutteau
Steven Coutteau
DSDipak Shah
Dipak Shah
The HD-grid multipolar mapping catheter has emerged as an invaluable tool for greater effectiveness of pulmonary vein isolation (PVI). In the cases described below, fractionated signals seen with the HD-grid catheter at the LAA and LSPV junction were ablated. These signals likely would not be visualized with conventional catheters and may cause recurrences due to incomplete PVI. The directional sensitivity limitations of bipolar electrogram recordings and the unique anatomy of the LAA-LSPV ridge further contribute to the challenge of evaluating pulmonary vein isolation. The HD-grid catheter’s ability to record bipoles parallel and perpendicular to the catheter splines and its high-density mapping capabilities provide a superior means of identifying gaps in ablation and detecting the low-voltage isthmus. Furthermore, factors such as ablation quality, catheter stability, and the thickness of the LAA-LSPV ridge influence the presence of fractionated signals and the success of PVI. Incorporating pre-procedure imaging modalities such as CT or MRI and real-time intracardiac echocardiography could enhance the tailored approach to address these challenges. Future developments in HD-grid technology, including contact force measurement during mapping, may offer additional insights into the nature of these signals. This case series highlights the significance of utilizing the HD-grid catheter for detailed interrogation of the LAA-LSPV ridge, ultimately leading to more effective PVI and improved outcomes in patients with afib

11 January 2021 in Cureus
Verified
Journal Article
Open access
PDF file
HLHarini Lakshman
Harini Lakshman
PAPal Satyajit Singh Athwal
Pal Satyajit Singh Athwal
APAnoosha Ponnapalli
Anoosha Ponnapalli
SASyed Ahmed
Syed Ahmed
NDNimit Dalal
Nimit Dalal
A 64-year-old African American male, with past medical history of hypertension, depression, and seizure disorder, presented with an episode of generalized tonic-clonic seizure. He was treated for seizures, and after 48 hours seizure-free, the patient started complaining of chest tightness and troponin levels were found to be 34.71 ng/mL. No evidence of myocardial infarction was found after extensive diagnostic workup, including cardiac catheterization. We suspect alternative causes of elevated troponin including post-seizure and transient takosubo cardiomyopathy.

31 August 2026 in Annals of Noninvasive Electrocardiology
Verified
Journal Article
Open access
PDF file
MCMedhat Chowdhury
Medhat Chowdhury
SDSanchit Duhan
Sanchit Duhan
ABAbdul Rasheed Bahar
Abdul Rasheed Bahar
MJMohamad Hasan Jawadi
Mohamad Hasan Jawadi
BKBijeta Keisham
Bijeta Keisham
MZMarcel Zughaib
Marcel Zughaib
Background: Ventricular tachycardia (VT) is a major cause of morbidity and mortality in patients with structural heart disease, yet real‐world comparisons between ischemic cardiomyopathy (ICM) and non‐ischemic dilated cardiomyopathy (NIDCM) remain limited. Methods: The national readmission database (2016–2020) was used to identify hospitalizations for VT. Cohorts were stratified based on underlying cardiomyopathy. A Propensity Score Matching (PSM) model matched ICM to NIDCM patients. Pearson's x2 test was applied to PSM‐matched cohorts to compare outcomes. Results: We identified 622,092 VT hospitalizations, of which 575,312 (92.4%) had ICM and 46,780 (7.5%) had NIDCM. Outcomes were compared using multivariable logistic regression and propensity score matching (25,919 matched pairs). Despite being younger, NIDCM patients had higher in‐hospital mortality (10.4% vs. 9.6%, p < 0.001; aOR 1.08), stroke (1.7% vs. 1.2%, aOR1.42), acute heart failure (65% vs. 59%, aOR 1.36), acute kidney injury (46.1% vs. 41.7%, aOR1.35), endotracheal intubation (13.1% vs. 14.5%, aOR 1.06), ICD implantation (3.9% vs. 3.5%, aOR1.23), and VT ablation (1.0% vs. 0.5%, aOR1.76). Readmission rates were significantly higher in NIDCM at 30 days (10.4% vs. 8.7%, p = 0.019), 90 days (22.7% vs. 20.0%, p = 0.483), and 180 days (30.7% vs. 27.3%, p = 0.001). In contrast, ICM patients had higher rates of sudden cardiac arrest (10.6% vs. 5.9%, aOR0.55), major adverse cardiovascular events (78.9% vs. 52.2%, aOR0.24), cardiogenic shock (18.4% vs. 12.1%, aOR0.59), ECMO (0.9% vs. 0.4%, aOR0.48), and LVAD use (0.5% vs. 0.3%, aOR0.58). Mortality declined over time in ICM (8.5% in 2016 to 8.2% in 2020, p ‐trend = 0.006), but not in NIDCM. Conclusion: These findings highlight distinct clinical profiles and emphasize the need for targeted management strategies for VT based on the cardiomyopathy subtype.